Studies heart failure in Ibadan, Nigeria, following patients over time
Follows adults in Ibadan, Nigeria, with acute and chronic heart failure over time.
Key facts
- Who runs it
- University College Hospital, Ibadan
- Where
- Ibadan, NigeriaSee the site
- Trial code
- Registry title
- The Ibadan Acute and Chronic Heart Failure Project
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 1 Jan 2015
- Expected to end
- 31 Dec 2030
- Type of study
- Observational, 2 groups
- Record updated
- 10 July 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with heart failure in Ibadan, Nigeria. It will follow their health over time.
- Age
- 18 to 100 years
- Sex
- All sexes can join.
- Disease stage
- All cases of heart failure.
Main reasons for not taking part
- People who do not agree to take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All cases of heart failure
Who cannot take part
- No consent to participate
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in Nigeria
- University College Hospital IbadanIbadan, NigeriaContact: Okechukwu Ogah, PhDTaking people
About the trial
What the trial wants to find out
Contemporary studies from South Africa and Nigeria have built on historical reports to demonstrate that the etiology and indeed case profile of acute HF (i.e. more women and younger individuals affected in the prime of their life) is different from high-income countries. As such, HF is now responsible for 7-10% of medical admissions in the region.
Read full original descriptionShow less
These are entirely based on studies on acute HF and few on chronic HF. The nexus between endemic infections such as tuberculosis (TB) and HIV/AIDS and other non-communicable or non-infectious risk factors and HF in Africa is scarcely documented.
This study will assess the long-term outcomes, risk factors, clinical phenotypes, and genomics of HF in Ibadan, Nigeria, estimate catastrophic healthcare cost associated with CHF and how it affects evidence-based care; understand cultural and social conceptions of HF in the city and by extension in Nigeria.
Data from each subject shall be obtained using a uniform and standardized case report forms (CRF). A detailed clinical documentation on cases of HF will be undertaken.
All variables will be summarized using appropriate descriptive statistics. Means and proportions will be estimated with two-tailed 95% confidence intervals. Specified patients' outcomes will also be summarized using proportions. Factors associated wit patient outcomes will be investigated using multivariable logistic regression models. Crude and adjusted Odds Ratio (OR) with 95% confidence intervals (CI) will be estimated.
The primary event outcome of the study will be mortality by cause. Secondary event outcomes will include non-fatal major events (both resulting in and not resulting in admission).
The 2 groups in the trial
- Acute heart failure
These are acutely decompensated heart failure
- Chronic heart failure
These are stable heart failure patients being followed up in the outpatient clinic
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Ibadan Acute and Chronic Heart Failure Project
- Plain-language title
- Studies heart failure in Ibadan, Nigeria, following patients over timeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05936957, who can take part
- Record updated
- 10 July 2023